Therefore, ACE inhibitors (ACEIs) and AT1 receptor blockers (ARBs) are applied for the treatment of cardiovascular diseases via blocking and/or reducing the adverse effects of Ang II [16]. Here, AGTR1 is linked to cardiovascular disorder.